论文标题
使用新型深残留和区域CNN的脑肿瘤MRI分类
Brain Tumor MRI Classification using a Novel Deep Residual and Regional CNN
论文作者
论文摘要
脑肿瘤分类对于临床分析和治疗患者的有效治疗计划至关重要。深度学习模型可帮助放射科医生在无需手动干预的情况下准确有效地分析肿瘤。但是,脑肿瘤分析由于其复杂的结构,质地,大小,位置和外观而具有挑战性。因此,开发了一种新型的深层残留和区域基于区域的RES-BRNET卷积神经网络(CNN),用于有效的脑肿瘤(磁共振成像)MRI分类。开发的Res-BRNET在修改的空间和残留块内采用了系统和边界的操作。此外,空间块提取物在抽象层面上的均匀性和边界定义的特征。此外,在目标水平上使用的残留块显着学习了不同类别的脑肿瘤的局部和全球纹理变化。在标准数据集上评估了开发的RES-BRNET的效率;从Kaggle和Figshare收集,其中包含各种肿瘤类别,包括脑膜瘤,神经胶质瘤,垂体和健康图像。实验证明,开发的RES-BRNET优于标准CNN模型,并取得了出色的性能(准确性:98.22%,灵敏度:0.9811,F-SCORE:0.9841和精度:0.9822)在挑战性的数据集上。此外,提出的RES-BRNET的性能表明了基于医学图像的疾病分析的强大潜力。
Brain tumor classification is crucial for clinical analysis and an effective treatment plan to cure patients. Deep learning models help radiologists to accurately and efficiently analyze tumors without manual intervention. However, brain tumor analysis is challenging because of its complex structure, texture, size, location, and appearance. Therefore, a novel deep residual and regional-based Res-BRNet Convolutional Neural Network (CNN) is developed for effective brain tumor (Magnetic Resonance Imaging) MRI classification. The developed Res-BRNet employed Regional and boundary-based operations in a systematic order within the modified spatial and residual blocks. Moreover, the spatial block extract homogeneity and boundary-defined features at the abstract level. Furthermore, the residual blocks employed at the target level significantly learn local and global texture variations of different classes of brain tumors. The efficiency of the developed Res-BRNet is evaluated on a standard dataset; collected from Kaggle and Figshare containing various tumor categories, including meningioma, glioma, pituitary, and healthy images. Experiments prove that the developed Res-BRNet outperforms the standard CNN models and attained excellent performances (accuracy: 98.22%, sensitivity: 0.9811, F-score: 0.9841, and precision: 0.9822) on challenging datasets. Additionally, the performance of the proposed Res-BRNet indicates a strong potential for medical image-based disease analyses.